Standard interferon vs placebo or control
End‐of‐treatment response · patients on HD with HCV infection
Standard interferon probably leads to higher end‐of‐treatment response compared with placebo or control (moderate certainty).
1 finding from 1 review
- Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes onlyRR 8.62 [3.03, 24.55]5 studies · 132 participantsModerate